RIGL
Rigel Pharmaceuticals Inc.
$26.95
-$1.23(-4.36%)
53
Overall
80
Value
27
Tech
52
Quality
Market Cap
$529.15M
Volume
537.05K
52W Range
$13.57 - $43.72
Target Price
$41.20
Key Metrics Overview
| Market Cap | $529.15M | P/E Ratio | 5.28 |
| 52W High | $43.72 | 52W Low | $13.57 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 122.4% | 52W Position | 44.4% |
| Overall Score | 53 | Value Score | 80 |
| Quality Score | 52 | Technical Score | 27 |
Growth Analysis
| EPS Current Est | $5.1 | EPS Next Est | $3.07 |
| EPS Growth Est | -39.8% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RIGL | $26.95 | -4.4% | 537.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rigel Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW